Myelodysplastic Syndrome (MDS)

Showing 51 - 75 of 77

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

AML-MDS Novel Prognostic Tests Clinical Study

Unknown status
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
    • Calgary, Alberta, Canada
    • +5 more
    Jan 30, 2017

    Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Cranbury (CPI-613)

    Withdrawn
    • Acute Myeloid Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Cranbury, New Jersey
      Cornerstone Pharmaceuticals, Inc
    Dec 27, 2016

    Myelodysplasic Syndromes and Risk Factors for Infection

    Unknown status
    • Myelodysplastic Syndrome (MDS)
    • +3 more
    • No intervention
    • Creteil, France
      Henri Mondor Hospital
    Dec 20, 2016

    Myelodysplastic Syndrome (MDS) Trial in Toronto

    Unknown status
    • Myelodysplastic Syndrome (MDS)
      • Toronto, Ontario, Canada
        Odette Cancer Center
      Nov 15, 2016

      Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Worldwide (birinapant, Azacitidine, Placebo)

      Terminated
      • Myelodysplastic Syndrome (MDS)
      • Chronic Myelomonocytic Leukemia (CMML)
      • Glendale, Arizona
      • +75 more
      Oct 18, 2016

      Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Treosulfan)

      Completed
      • Acute Myeloid Leukemia (AML)
      • Myelodysplastic Syndrome (MDS)
      • Birmingham, Alabama
      • +22 more
      Oct 10, 2016

      Myelodysplastic Syndrome (MDS) Trial in Houston (TXA127)

      Terminated
      • Myelodysplastic Syndrome (MDS)
      • Houston, Texas
        MD Anderson Leukemia Department
      Aug 29, 2016

      Acute Myelogenous Leukemia (AML), Multiple Myeloma (MM), Myelodysplastic Syndrome (MDS) Trial in Chicago, Ann Arbor, Fairfax

      Unknown status
      • Acute Myelogenous Leukemia (AML)
      • +3 more
      • Chicago, Illinois
      • +2 more
      Apr 18, 2016

      Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Remission, Chronic Myelogenous Leukemia (CML) Trial

      Completed
      • Acute Myeloid Leukemia in Remission
      • +7 more
      • Kansas City, Kansas
      • +1 more
      Feb 25, 2016

      Leukemias, Acute Myeloid Leukemia (AML), Acute Lymphocytic Leukemia (ALL) Trial in Chapel Hill (Terameprocol (EM-1421))

      Terminated
      • Leukemias
      • +7 more
      • Terameprocol (EM-1421)
      • Chapel Hill, North Carolina
        UNC, Lineberger Comprehensive Cancer Center
      Feb 20, 2016

      Myelodysplastic Syndrome (MDS) Trial in Spain (Azacitidine)

      Completed
      • Myelodysplastic Syndrome (MDS)
      • Jerez, Cádiz, Spain
      • +8 more
      Jan 25, 2016

      Myelodysplastic Syndrome (MDS), Myelofibrosis (MF) Trial in Australia, United States (KB004, Monoclonal Antibody)

      Suspended
      • Myelodysplastic Syndrome (MDS)
      • Myelofibrosis (MF)
      • KB004, Monoclonal Antibody
      • Palo Alto, California
      • +8 more
      Nov 13, 2015

      Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in Canada, United Kingdom, United States (Azacitidine,

      Terminated
      • Acute Myeloid Leukemia (AML)
      • Myelodysplastic Syndrome (MDS)
      • Houston, Texas
      • +7 more
      Apr 22, 2015

      Hematologic Malignancy, Myelodysplastic Syndrome (MDS), Aplastic Anemia Trial in Durham (haplo/cord transplant)

      Completed
      • Hematologic Malignancy
      • +2 more
      • haplo/cord transplant
      • Durham, North Carolina
        Duke University Medical Center Pediatric Blood and Marrow Transp
      Mar 16, 2015

      Myelodysplastic Syndrome (MDS) Trial in Worldwide (Thymoglobulin®, Rabbit Anti-thymocyte Globulin (rATG))

      Terminated
      • Myelodysplastic Syndrome (MDS)
      • Thymoglobulin®, Rabbit Anti-thymocyte Globulin (rATG)
      • Paris, France
      • +6 more
      Mar 17, 2015

      Chimerism in Refractory Cytopenia Transplanted With Reduced

      Completed
      • Refractory Cytopenia of Childhood
      • +3 more
        • Frankfurt am Main, Hessen, Germany
          University Children´s Hospital
        Jan 14, 2015

        Acute Myelogenous Leukemia (AML), Chronic Myelogenous Leukemia (CML), Acute Lymphoblastic Leukemia (ALL) Trial in Durham (WT1

        Terminated
        • Acute Myelogenous Leukemia (AML)
        • +4 more
        • WT1 derived peptides
        • Durham, North Carolina
          Duke Comprehensive Cancer Center
        Dec 7, 2013

        Myelodysplastic Syndrome (MDS) Trial in United States (ezatiostat HCl (Telintra®))

        Terminated
        • Myelodysplastic Syndrome (MDS)
        • ezatiostat hydrochloride (Telintra®)
        • Maywood, Illinois
        • +4 more
        Nov 20, 2013

        Myelodysplastic Syndrome (MDS) Trial in United States (ezatiostat HCl (Telintra®))

        Terminated
        • Myelodysplastic Syndrome (MDS)
        • ezatiostat hydrochloride (Telintra®)
        • Concord, California
        • +6 more
        Nov 20, 2013

        Blood And Marrow Transplantation, Leukemia, Lymphoma Trial in United States (Fludarabine, Clofarabine, Busulfan, ATG, TBI

        Unknown status
        • Blood And Marrow Transplantation
        • +6 more
        • Fludarabine, Clofarabine, Busulfan, ATG, TBI (Myeloablative)
        • Fludarabine, Melphalan, ATG (Reduced Intensity)
        • La Jolla, California
        • +3 more
        Nov 14, 2013

        Myelodysplastic Syndrome (MDS) Trial in Decatur, Huntsville (Arsenic Trioxide)

        Terminated
        • Myelodysplastic Syndrome (MDS)
        • Arsenic Trioxide
        • Decatur, Alabama
        • +1 more
        Oct 10, 2012

        Myelodysplastic Syndrome (MDS) Trial in Maywood, Worcester (Ezatiostat Hydrochlorine)

        Completed
        • Myelodysplastic Syndrome (MDS)
        • Ezatiostat Hydrochlorine
        • Maywood, Illinois
        • +2 more
        May 30, 2012

        Myelodysplastic Syndrome (MDS) Trial in United States (Ezatiostat Hydrochloride)

        Completed
        • Myelodysplastic Syndrome (MDS)
        • Ezatiostat Hydrochloride
        • Tucson, Arizona
        • +35 more
        Oct 10, 2011

        Myelodysplastic Syndrome (MDS) Trial in United States (lintuzumab, lenalidomide)

        Completed
        • Myelodysplastic Syndrome (MDS)
        • Birmingham, Alabama
        • +7 more
        Oct 7, 2011

        Acute Myelogenous Leukaemia (AML), Myelodysplastic Syndrome (MDS) Trial in Paris (5 azacytidine - VALPROIC acid- Retinoic acid)

        Completed
        • Acute Myelogenous Leukaemia (AML)
        • Myelodysplastic Syndrome (MDS)
        • 5 azacytidine - VALPROIC acid- Retinoic acid
        • Paris, France
          Chu Saint Louis
        May 6, 2011